Details for 2001992582

Up to date per 03.04.2026

Actions

Title / Product Name

VERWENDUNG VON IL-1 INHIBITOREN UND TNF ANTAGONISTEN ZUM TEIL IN KOMBINATION MIT RECOMBINANTEN HUMANEN ERYTHROPOIETINEN ZUR BEHANDLUNG VON ANAEMIE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2001992582

EP Publication Number

1330260

E-Number

666079

Language

PCT Number

US01046205

Publication Date

30.07.2003 A

07.05.2014 B1

Registration Date

07.05.2014

AT Publication Date

15.05.2014

Application Date

30.10.2001

Registration Number

Priorities

31.10.2000

244792 P

02.10.2001

969739

IPC

A61K 38/18 20060101AFI20131111BHEP

Maximum Duration of Protection

30.10.2021

Owner

AMGEN INC.One Amgen Center Drive Thousand Oaks, CA 91320-1799US

Representative

No representatives present

Inventor

KAY, Jonathan62 Olde Field Road Newton Center, ME 02459-2734US

MCCABE, Dorothy10708 Pimlico Moorpark, CA 93021US

NEWMARK, Richard998 Via Candella Newbury Park, CA 91320US

COCCIA, Marco, A.3505 Bean Creek Road Scotts Valley, California 95066US